Microplastic Contamination in Commercial Antiglaucoma Eye Drops: Occurrence and Material Characterization
17th European Glaucoma Society (EGS) Congress, Brussels, Belçika, 30 Mayıs - 02 Haziran 2026, ss.64, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Basıldığı Şehir: Brussels
- Basıldığı Ülke: Belçika
- Sayfa Sayıları: ss.64
- Recep Tayyip Erdoğan Üniversitesi Adresli: Evet
Özet
PURPOSE
The purpose
of this study was to investigate the presence, abundance, physical
characteristics, and polymer composition of microplastics in commercially
available antiglaucoma eye drops commonly used for long-term treatment. By
analysing seven ophthalmic formulations under controlled laboratory conditions,
this study aimed to assess whether eye drops may represent a potential direct
source of microplastic exposure to the ocular surface and to highlight the need
for improved quality control in pharmaceutical products.
METHODS
Seven commercially available antiglaucoma
eye drops commonly prescribed for chronic ocular use were included in the
study. All samples were processed under controlled laboratory conditions to
minimize airborne and procedural contamination. The eye drop solutions were
directly filtered through pre-cleaned filters, and procedural blanks were
prepared in parallel to monitor possible background contamination. After
filtration, the retained particles were visually examined and classified
according to their morphological characteristics, including particle type,
colour, and size. Suspected microplastic particles were then analysed using
Infrared (IR) and Raman spectroscopy for polymer identification. Only particles
confirmed as synthetic polymers by spectroscopic analysis were considered as
microplastics. Microplastic abundance was calculated for each eye drop
formulation and expressed as the number of particles per milliliter (items/mL).
The detected particles were further evaluated according to their morphology and
polymer composition to assess possible contamination sources related to
packaging, manufacturing, or storage conditions.
RESULTS
Microplastics were detected in
4 out of the 7 analysed
samples. A total of 16 microplastic particles were identified in the ophthalmic
solutions. All detected microplastics were classified as fragment-type
particles, while no fibres or films were observed. Five different colours were
recorded among the detected microplastics: transparent, white, blue, yellow,
and black. The most dominant colour was transparent particles, accounting for
38% of the total, followed by white particles (25%), blue particles (19%),
yellow particles (13%), and black particles (6%). Polymer identification
performed using Shimadzu AIRsight Infrared/Raman spectroscopy confirmed the
presence of two synthetic polymer types: polystyrene (PS) and polyethylene
(PE). Polystyrene was the dominant polymer, representing 93.7% of the identified particles,
while polyethylene accounted for 6.3%.
CONCLUSION
Microplastics
were detected in most of the analysed antiglaucoma eye drop samples, indicating
that ophthalmic solutions may represent a direct and previously overlooked
source of microplastic exposure to the ocular surface. Given that antiglaucoma
eye drops are commonly used chronically and applied directly to the eye, the
presence of microplastics may raise concerns regarding long-term ocular
exposure and potential implications for ocular surface health. These findings
highlight the need for improved quality control in pharmaceutical
manufacturing, packaging, and storage processes, as well as further
toxicological studies to assess the possible risks associated with repeated
microplastic exposure through ophthalmic formulations.